[PPB] YoY Annualized Quarter Result on 31-Dec-2012 [#4]

Announcement Date
27-Feb-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Dec-2012 [#4]
Profit Trend
QoQ- 17.8%
YoY- -14.1%
Quarter Report
View:
Show?
Annualized Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 4,048,314 3,701,008 3,312,917 3,017,926 2,710,539 2,274,036 2,053,769 11.96%
PBT 1,181,122 1,028,144 1,063,417 916,814 1,056,580 1,131,486 1,455,390 -3.41%
Tax -105,003 -89,227 -72,478 -48,617 -44,072 777,740 173,649 -
NP 1,076,119 938,917 990,939 868,197 1,012,508 1,909,226 1,629,039 -6.67%
-
NP to SH 1,051,311 916,779 982,573 842,152 980,372 1,884,949 1,615,964 -6.91%
-
Tax Rate 8.89% 8.68% 6.82% 5.30% 4.17% -68.74% -11.93% -
Total Cost 2,972,195 2,762,091 2,321,978 2,149,729 1,698,031 364,810 424,730 38.28%
-
Net Worth 19,916,397 16,822,242 15,649,523 14,273,418 14,060,028 13,277,624 14,083,818 5.94%
Dividend
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Div 296,374 272,664 296,392 237,099 272,664 1,043,241 865,419 -16.34%
Div Payout % 28.19% 29.74% 30.16% 28.15% 27.81% 55.35% 53.55% -
Equity
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Net Worth 19,916,397 16,822,242 15,649,523 14,273,418 14,060,028 13,277,624 14,083,818 5.94%
NOSH 1,185,499 1,185,499 1,185,569 1,185,499 1,185,499 1,185,502 1,185,506 -0.00%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 26.58% 25.37% 29.91% 28.77% 37.35% 83.96% 79.32% -
ROE 5.28% 5.45% 6.28% 5.90% 6.97% 14.20% 11.47% -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 341.49 312.19 279.44 254.57 228.64 191.82 173.24 11.96%
EPS 88.68 77.33 82.88 71.04 82.70 159.00 136.31 -6.91%
DPS 25.00 23.00 25.00 20.00 23.00 88.00 73.00 -16.34%
NAPS 16.80 14.19 13.20 12.04 11.86 11.20 11.88 5.94%
Adjusted Per Share Value based on latest NOSH - 1,185,499
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 284.58 260.17 232.88 212.15 190.54 159.86 144.37 11.96%
EPS 73.90 64.45 69.07 59.20 68.92 132.50 113.60 -6.91%
DPS 20.83 19.17 20.84 16.67 19.17 73.34 60.84 -16.35%
NAPS 14.0004 11.8254 11.001 10.0336 9.8836 9.3336 9.9004 5.94%
Price Multiplier on Financial Quarter End Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 -
Price 15.90 14.30 16.14 11.60 17.16 17.26 15.96 -
P/RPS 4.66 4.58 5.78 4.56 7.51 9.00 9.21 -10.72%
P/EPS 17.93 18.49 19.47 16.33 20.75 10.86 11.71 7.35%
EY 5.58 5.41 5.13 6.12 4.82 9.21 8.54 -6.84%
DY 1.57 1.61 1.55 1.72 1.34 5.10 4.57 -16.30%
P/NAPS 0.95 1.01 1.22 0.96 1.45 1.54 1.34 -5.56%
Price Multiplier on Announcement Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 29/02/16 27/02/15 28/02/14 27/02/13 29/02/12 28/02/11 02/03/10 -
Price 16.00 14.58 15.92 12.22 17.20 16.50 16.16 -
P/RPS 4.69 4.67 5.70 4.80 7.52 8.60 9.33 -10.82%
P/EPS 18.04 18.85 19.21 17.20 20.80 10.38 11.86 7.23%
EY 5.54 5.30 5.21 5.81 4.81 9.64 8.44 -6.77%
DY 1.56 1.58 1.57 1.64 1.34 5.33 4.52 -16.24%
P/NAPS 0.95 1.03 1.21 1.01 1.45 1.47 1.36 -5.80%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment